We aimed to assess whether disease-free survival (DFS) could serve as a reliable surrogate endpoint for overall survival (OS) in adjuvant trials of pancreatic cancer. | Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer A meta-analysis of 20 randomized controlled trials